Significant Medication Error Leads to Resident's Death
Summary
The facility failed to ensure that a resident was free from significant medication errors. Specifically, Resident #2's orders for Fentanyl were erroneously changed from being administered every 3 days to being administered daily. As a result, Resident #2 was administered Fentanyl patches daily for three consecutive days, contrary to the prescribed order of every 72 hours. This error had the potential to cause serious adverse outcomes, including overdose and death, placing Resident #2 in Immediate Jeopardy. Resident #2 was admitted with multiple diagnoses, including Rheumatoid Arthritis, Pain Unspecified, and Type 2 Diabetes. The resident had a Brief Interview for Mental Status score indicating no cognitive impairment. The medical record revealed that the resident had a physician's order for Fentanyl patches to be applied every 72 hours. However, due to a transcription error, the order was entered into the facility's electronic system as a daily administration. This error was not caught by the nursing staff, who administered the patches daily. Interviews with the Director of Nursing, Nurse Practitioner, and Licensed Practical Nurses revealed that there were multiple points where the error could have been identified and corrected. The NP stated that the intention was to increase the Fentanyl dosage but maintain the 72-hour interval. However, the order was incorrectly entered into the electronic system and not questioned by the verifying nurse. The LPNs involved admitted to noticing the discrepancy but failed to clarify the order with the NP or DON. This series of actions and inactions led to the inappropriate administration of the medication, ultimately resulting in the resident's death.
Removal Plan
- A Medical Record review was conducted by the Director of Nursing to identify residents who have active orders for Fentanyl Transdermal patches to ensure the order was transcribed correctly.
- An audit of medications in the medication carts was conducted by the Clinical Interdisciplinary Team (IDT) to ensure the labels on the medication cards match the order in Matrix Care.
- A root cause analysis was conducted by the Clinical Interdisciplinary Team.
- The Nurse Practitioner was educated by the Signature State Care Consultant and the Director of Nursing on Order Entry in Matrix Care.
- The Nurse Practitioner attended an on-line Matrix Care Provider Training.
- The Director of Nursing educated the Unit Manager #2 to ensure the order is transcribed accurately and clarify any discrepancies with the provider before verifying the order.
- Unit Managers #1, #2, and #3 and licensed nurses were educated to verify orders for accuracy before activating them and to clarify any discrepancies with the providers.
- All licensed staff were educated by the Director of Nursing to ensure the label on the medication card matches the medication order in MatrixCare and to call the provider to clarify any discrepancies.
- An Ad Hoc QAPI was held with the Leadership Team and Medical Director to discuss the incident, the investigation outcome and discuss the Plan of Correction.
- The DON or Unit Manager will verify the medication card labels match the order in Matrix Care for 5 days per week for 1 week then, 3 times per week for 3 weeks then, 1 time per week for 1 month.
- A pharmacy nurse consultant will audit all medication carts to ensure the labels on the medication cards match the order in MatrixCare until the QAPI team determines compliance.
- Findings of audits will be reported to the QAPI Committee which consists of the Administrator, Director of Nursing, Unit Managers, Staff Development Coordinator, Social Services Director, Maintenance Director, Dietary Manager, Life Enrichment Director, Rehab Manager, and Medical Director.
- QAPI meetings will be held weekly for 4 weeks, then 2 times per month for the next 30 days, then monthly thereafter until the QAPI Committee determines substantial compliance.
- Regional oversite has been in place daily since the date Misappropriation of Resident Property was reported to Health Facilities Commission regarding Transdermal Fentanyl Patches.
- The Senior (Sr.) Signature State Care Consultant has been in the facility assisting with interviews, audits, education, process changes, attending QAPI meetings, and oversight of compliance with process changes.
- Regional oversite has occurred onsite or by phone from the Sr. State Signature Care Consultant, the Regional President of Clinical Operations, or the Regional President of Operations.
- The Regional team has collaborated with the facility team on process changes and attended Ad HOC QAPI meetings via phone to discuss audit findings and develop a plan of correction.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.